ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645809 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645809; 2) Community: the network communities that were significantly associated with the response to NSC 645809; 3) Molecule: the relationships between components within communities and NSC 645809; 4) MDR: the compounds that were significantly associated with the NSC 645809.

NSC Compound Enrichment Correlation
NSC 746087 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.0430505868034764 0.25838921
NSC 746684 7-{[3-(dibutylamino)propyl]amino}-5-imino-1,3,6-triphenyl-5,6-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dithione 0.0430505868034764 0.35694727
NSC 755427 Null 0.0430505868034764 0.53539297
NSC 758359 N3-[1-(3-phenoxybenzyl)-1H-1,2,3-triazol-4-yl]methyl-2-(4-fluoroanilino)nicotinamide 0.0430505868034764 0.0010627846
NSC 758662 Lovastatin [USAN] 0.0430505868034764 0.021109154
NSC 104942 EUPAROTIN 0.0435808621943462 0.042639468
NSC 138425 Kinamycin C 0.0435808621943462 0.36553611
NSC 185057 Acetic acid, phenoxy-, 6-[[(aminothioxomethyl)hydrazono]methyl]-3-pyridinyl ester 0.0435808621943462 0.4560219
NSC 306911 .beta.-D-Glucopyranose, 2,3-O-(diethylstannylene)- 0.0435808621943462 0.0083139416
NSC 313985 Gold(1+), bis(trimethylphosphine)-, chloride 0.0435808621943462 -0.0235449
Total:98  Current:91    [First] [Prev] [Next] [Last]